SERPINB3 and neoplasm: The improved anticancer effect of siSERPINB3 combined with cisplatin compared to that of control NPs was further demonstrated by histological analysis (Figure 7E), which revealed that SERPINB3 was effectively inhibited and that cleaved caspase‐3 expression was increased and ki‐67 was decreased in the tumor tissues.